Lect 6- CAD & Thromboembolic Stroke Flashcards

1
Q

myocardial ischemia definition

A

imbalance b/w myocardial oxygen supply and demand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

contributing factors for myocardial ischemia

A
  1. increased sympathetic outflow= increased myocardial O2 demand
  2. decreased coronary blood flow= decreased myocardial O2 supply
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

coronary artery disease (CAD) definition

A

condition in which the coronary arteries are narrowed by the formation of atherosclerotic plaques (Means there is an atherosclerotic state where blood flow is reduced)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2 types of plaques

A

○ Unstable= fibrous cap is thin and can rupture at any time
○ Stable= outer layer pretty thick
§ Still have narrowing but we will at least avoid having a rupture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

main symptoms of myocardial ischemia

A
  1. angina pectoris
  2. decreased exercise tolerance (since when you are exercising, your symp NS is activated which means heart needs more O2 but if its already getting not a lot, we cannot keep up)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2 distinct characteristics of MI

A
  1. sudden interruption of blood supply to myocardium by rupture of an atherosclerotic plaque resulting in thrombosis
  2. myocardial function is compromised & tissue can become necrotic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

myocardial ischemia treatment goals

A
  • short-term goal= prevent/ reduce symptoms of angina

* long-term goals= prevent events of myocardial ischemia (MI, arrhythmias, heart failure) and reduce mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

drugs used in IHD and CAD

A

• Improve the balance by either increase O2 supply to myocardium or decrease O2 demand by myocardium
○ Some can do both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA of organic nitrates

A

PRODRUGS
Upon metabolism release NO (potent vasodilator) → NO is gas → gets to cells and past plasma memb very easily → stim guanylyl cyclase → converts GTP to cGMP → has 2 diff mechanisms that will result in smooth muscle relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

hemodynamic effects of organic nitrates

A
  1. low doses PREFERENTIALLY dilate veins (dec venous return & preload, dec left & right ventricular chamber size) to need to use less force to pump blood out
  2. High dose= will also dilate arteries → creates compensatory tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CV effects of low-mod doses of organic nitrates

A
  1. vasodilate epicardial vessels (>200 um diameter)
  2. do NOT impair autoregulation in smaller vessels
  3. ) decrease intracavity systolic/ diastolic pressures → increase the blood flow to the subendocardium
  4. ) dilate cardiac veins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

organic nitrates effect on myocardial O2 requirements

A

inc venous capacitance → dec venous return → dec preload → reduction of O2 demand and inc blood flow to subendocardium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

antianginal effect of organic nitrates

A
  1. PRIMARY EFFECT= reduction of venous return and myocardial O2 demand
  2. dilation of epicardial coronary arteries → improved blood flow/ O2 supply
  3. NO in plts → antiplatelet effect (modest but IMPORTANT effect)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

tolerance in organic nitrates

A

long term use of high doses may lead to attenuation of their pharmacological effects (potency is being reduced)
TACHYPHYLAXIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

side effects of organic nitrates

A

HEADACHE (due to vasodilation in the brain)

transient dizziness/ weakness, postural/ orthostatic hypotension, drug rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PDE5 inhibitors with nitrates

A

CAUTION: combo of PDE5 inhibitors (sildenafil, tadalafil, vardenafil) with nitrates may cause severe hypotension!

17
Q

MOA of interaction b/w PDE5 inhibitors and nitrates

A

• cGMP is inactivated by PDE5 (cyclic molecule converted to linear molecule) → so when we block it cGMP is not inactivated → effect is much more pronounced → severe vasodilation → severe hypotension or maybe even comatose state

18
Q

effects of stimulating the beta-1 receptor in the heart

A

increase in:

  • chrono (heart rate)
  • dromo (AV nodal conduction)
  • ionotropic (contraction force)
19
Q

effect of beta-adrenoreceptor antagonists

A

block the beta-1 receptor to decrease O2 demand

20
Q

B1-blockers are effective in treatment of ___

A

exertional angina= cardioprotective effects

unstable angina & MI= reduce recurrent episodes and improve mortality

21
Q

caution with b1-blockers

A

in pts with limited cardiac reserve, b-blockers can result in profound decreases in left ventricular function

22
Q

differential effects between CCBs

A

DHP has more members so it affects blood vessels; non-DHP affects heart (only one heart and a lot of blood vessels)

23
Q

CCBs in treatment of IHD

A

Non-DHP to decrease contraction of heart so result will be decreased demand
DHP would dilate vessels which would improve supply to the heart

24
Q

heparin parenteral anticoagulants MOA

A

facilitate binding of thrombin to antithrombin so coagulation factors are not activated

25
Q

warfarin (Coumadin) MOA

A

vit K antagonist= inhibits vit K epoxide reductase so Vit K is not reduced to activate coagulation factors

26
Q

anticoags use in CAD

A

usually used w/ other drugs to achieve better therapeutic outcome

27
Q

MOA of aspirin 50-325 mg/day

A

○ Inhibits COX enzymes → COX converts arachodonic acid to prostaglandins
• Low therapeutic doses= primarily inhibits COX1
○ Stop prod of thromboxane A2 (which usually activates and aggregates plts)
○ Prostaglandin synthesis not affected

28
Q

Aggrenox= aspirin/extended-release dipyridamole

A

○ Inhibits uptake of adenosine in plts → more adenosine on surface available to activate receptors
○ Inhibits phosphodiesterases (at least 10 subtypes; inhibits mostly ones that prefer cGMP than cAMP) → increased cGMP which causes smooth muscle relaxation and dilation

29
Q

Aggrenox side effect

A

headache